Mesoblast MESO
NASDAQ MESO
$12.29 -0.26 (-2.07%)
As of: Oct 23, 2026 · 3:41 PM EDT

Mesoblast (MESO) Net Debt Issuances and Repayments (2018 - 2021)

Updated

Analysis

Mesoblast (MESO) Net Debt Issuances and Repayments (2018 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,132.61 Bn 1,101.20 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.68 Bn 555.54 Bn 17.30 Bn -4.36 Bn
3 AbbVie 506.54 Bn 479.65 Bn 12.70 Bn -2.00 Bn
4 Merck 358.37 Bn 312.75 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 292.65 Bn 256.64 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.69 Bn 239.37 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.83 Bn 193.23 Bn 7.24 Bn -
8 Gilead Sciences 195.33 Bn 169.52 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.37 Bn 118.01 Bn 10.94 Bn 64.00 Mn
10 Mesoblast 1.59 Bn 1.16 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 55.46 Mn
Mar 31, 2019 14.62 Mn
Sep 30, 2018 28.95 Mn
API Access

Mesoblast Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=MESO&period=max&api_key=YOUR_API_KEY